HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Family styles of coping in end stage renal disease.

AbstractThe introduction of a serious life-threatening illness such as end stage renal disease (ESRD) is an added stress dimension to the already enormous demands placed on the contemporary family system. The purpose of the present study was to identify qualitatively and describe selected aspects of psychosocial adaptation among the families of ESRD patients experiencing four primary modes of dialytic therapy: incenter hemodialysis, home dialysis, continuous ambulatory peritoneal dialysis (CAPD), and continuous cyclic peritoneal dialysis (CCPD). Five family coping styles emerged from content analysis of the data collected from 50 family members at four time periods. These styles have been labelled: Remote Family Style, Enfolded Family Style, Altered Family Style, Distressed Family Style, and Receptive Family Style.
AuthorsM J Flaherty, M E O'Brien
JournalANNA journal / American Nephrology Nurses' Association (ANNA J) Vol. 19 Issue 4 Pg. 345-9, 366; discussion 350 (Aug 1992) ISSN: 8750-0779 [Print] UNITED STATES
PMID1520024 (Publication Type: Case Reports, Journal Article, Research Support, U.S. Gov't, P.H.S.)
Topics
  • Adaptation, Psychological
  • Adult
  • Aged
  • Aged, 80 and over
  • Family (psychology)
  • Female
  • Humans
  • Kidney Failure, Chronic (nursing, psychology, therapy)
  • Male
  • Middle Aged
  • Nursing Methodology Research
  • Renal Dialysis (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD